JI
Sen. James Inhofe (R-OK) sold $15K-$50K of CRSP stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of CRISPR Therapeutics AG (CRSP) stock worth $15K-$50K in a STOCK Act filing on Jun 20, 2018.
The trade happened on Jun 19, 2018, 1 day before it was made public.
CRSP has moved -31.3% since the trade date, from $62.06 to $42.62 (Nov 12, 2026 close).
- Traded
- Jun 19, 2018
- Disclosed
- Jun 20, 2018
- Filing delay
- 1 day
- Price since
- -31.3%
- Source
- STOCK Act disclosure